Ask @MichaelHarNoy:

This user hasn’t answered any questions yet

Ask Michael Har-Noy a question now

  • 0
  • 0

About Michael Har-Noy:

Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, Ltd., intends to conduct a Phase I/II study that compares different treatment schedules involving AlloStimTM combined with cryoablation. Dr. Michael Har-Noy says that the AlloStimTM, consisting of bioengineered immune cells, is formula